Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Conor McNamara
RBC
Conor McNamara
RBC Capital
Wall Street Analyst
★★☆☆☆
#2084
on 13Foresight · ranked by our own returns
50%
Success Rate
+0.7%
Average Return
7 of 14 calls profitable · -17.2% vs benchmark
📈 Across the calls we could measure, roughly 50% of Conor McNamara's ratings turned a profit when each position was held for 1 year — averaging +0.7% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

36 Buy 7 Hold 0 Sell
Conor's Stock Coverage 12 ratings · 2026-06-20
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
BIO
Bio-Rad Laboratories
 Sep 02, 2025 BUY Buy
+23.7% avg upside
8 analysts
$437.00
54.80% Upside
 -2.1%
DHR
Danaher
 Sep 02, 2025 BUY Strong Buy
+21.9% avg upside
45 analysts
$241.00
35.95% Upside
 -12.3%
ILMN
Illumina
 Sep 02, 2025 BUY Buy
-10.1% avg upside
30 analysts
$124.00
23.45% Downside
 +62.6%
QDEL
QuidelOrtho
 Sep 02, 2025 BUY Buy
+183.5% avg upside
13 analysts
$62.00
353.52% Upside
 -53.5%
RGEN
Repligen
 Sep 02, 2025 BUY Strong Buy
+28.4% avg upside
25 analysts
$205.00
55.19% Upside
 +9.4%
TECH
Bio-Techne
 Sep 02, 2025 BUY Strong Buy
+38.3% avg upside
21 analysts
$73.00
26.04% Upside
 +5.4%
TMO
Thermo Fisher
 Sep 02, 2025 BUY Strong Buy
+26.8% avg upside
38 analysts
$561.00
20.72% Upside
 -5.0%
NTRA
Natera
 Sep 02, 2025 BUY Strong Buy
+7.4% avg upside
26 analysts
$268.00
15.72% Upside
 +33.7%
AVTR
Avantor
 Sep 02, 2025 BUY Buy
+49.6% avg upside
26 analysts
$16.00
66.93% Upside
 -28.8%
MRVI
Maravai Lifesciences Holdings
 Sep 02, 2025 BUY Strong Buy
+175.0% avg upside
17 analysts
$5.00
3.78% Downside
 +75.1%
SOPH
SOPHiA GENETICS
 Sep 02, 2025 BUY Strong Buy
+75.8% avg upside
7 analysts
$7.00
28.12% Upside
 +41.5%
OABI
OmniAb
 Sep 02, 2025 BUY Strong Buy
+232.4% avg upside
10 analysts
$3.00
28.30% Upside
 +44.3%
🔒 7 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Conor McNamara — Frequently Asked Questions
How accurate are Conor McNamara's stock ratings?
Based on the calls 13Foresight could measure, about 50% of Conor's ratings were profitable over a one-year hold, with an average return of +0.2% per rating, or -17.4% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Conor ranked on 13Foresight?
Conor McNamara is currently ranked #2084 with a 2-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Conor cover?
Conor most recently has ratings on BIO, DHR, ILMN, QDEL, RGEN, TECH, TMO, NTRA, AVTR, MRVI, SOPH, OABI. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.